Interview featuring Frontage's Clinical Service's VP, Gary Steidl to discuss key points for success in a clinical trial.
Register to gain access to gated resources.
You must register to view this resource.
Thank you for registering!
You now have the option of downloading the resource or viewing the web version below.
In this Q&A, Nan Zhang MD PhD, Vice President of Global Central Lab and Biomarker Services at Frontage, speaks on the role of analytical and central laboratories in providing accurate laboratory data and seamless logistics services.
A number of the abuse-deterrent formulations in development and available on the market utilize hard-to-crush tablet technologies. Frontage possesses wide experience in running studies with controlled substances. Frontage provided full support in developing the protocol, revising study methodology, developing full package for IRB submission, including Informed Consent Form.
Programs that need to include women in their FIH (first in human) studies will find that successful enrollment of women is achievable; however, it requires a concerted effort, with the correct strategies and proper support. In this paper, we explore the challenges in recruiting women for FIH studies and present a set of practices that have proven successful in improving the recruitment rates of women for these studies.